Meta-analysis of placebo remission rate for patients with moderately to severely active Crohn's disease

被引：0
|
作者：
Loftus, Edward, Jr.
Wu, Eric
Johnson, Scott
Chao, Jingdong
Mulani, Parvez
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Anal Grp Inc, Boston, MA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
970
引用
收藏
页码：S380 / S381
页数：2
相关论文
共 50 条
  • [31] Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately to Severely Active Crohn's Disease
    Sands, Bruce E.
    Gasink, Christopher
    Jacobstein, Douglas
    Ott, Elyssa
    Lang, Yinghua
    Ramachandran, Paraneedharan
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S329 - S330
  • [32] Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease
    Harris, Sarah
    Feagan, Brian G.
    Hanauer, Stephen
    Vermeire, Severine
    Ghosh, Subrata
    Yan, Jim
    Wu, Chun
    Hu, Yanhua
    Maddux, Rachel
    Wolf, Douglas C.
    D'Haens, Geert
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (06) : 2044 - 2054
  • [33] Factors that influence the placebo remission rate in Crohn's disease trials
    Su, CY
    Lichtenstein, GR
    Krok, K
    Brensinger, C
    Lewis, JD
    GASTROENTEROLOGY, 2002, 122 (04) : A497 - A497
  • [34] Placebo Response Rate in Clinical Trials of Fistulizing Crohn's Disease: Systematic Review and Meta-analysis
    Ford, Alexander C.
    Luthra, Pavit
    Hanauer, Stephen B.
    Travis, Simon P.
    Harris, M. Scott
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) : 1981 - 1990
  • [35] Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease
    Louis, Edouard
    Lee, Wan-Ju
    Litcher-Kelly, Leighann
    Ollis, Sarah
    Pranschke, Emma
    Fitzgerald, Kristina
    Lacerda, Ana Paula
    Neimark, Ezequiel
    Gonzalez, Yuri Sanchez
    Panes, Julian
    ADVANCES IN THERAPY, 2024, 41 (09) : 3678 - 3705
  • [36] Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
    Prantera, Cosimo
    Lochs, Herbert
    Grimaldi, Maria
    Danese, Silvio
    Scribano, Maria Lia
    Gionchetti, Paolo
    GASTROENTEROLOGY, 2012, 142 (03) : 473 - U124
  • [37] Dual Advanced Therapies and Novel Pharmacotherapies for Moderately to Severely Active Crohn's Disease
    Tse, Chung Sang
    Dulai, Parambir S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 283 - 298
  • [38] BIOLOGIC DRUGS FOR INDUCTION OF REMISSION IN CROHN'S DISEASE: A NETWORK META-ANALYSIS
    Gordon, Morris
    Sinopoulou, Vassiliki
    Aali, Ghazaleh
    Akobeng, Anthony
    Freeman, Suzanne C.
    Masitara, Masitara
    Khan, Muhammad Ibrahim
    Cherayath, Rose
    Sherafat, Alireza
    Alqusous, Fareed
    Elleithy, Assem
    Moran, Gordon W.
    GASTROENTEROLOGY, 2022, 162 (07) : S608 - S609
  • [39] BIOLOGIC DRUGS FOR MAINTENANCE OF REMISSION IN CROHN'S DISEASE: A NETWORK META-ANALYSIS
    Gordon, Morris
    Sinopoulou, Vassiliki
    Akobeng, Anthony
    Freeman, Suzanne C.
    Masitara, Masitara
    Khan, Muhammad Ibrahim
    Cherayath, Rose
    Sherafat, Alireza
    Alqusous, Fareed
    Elleithy, Assem
    Aali, Ghazaleh
    Moran, Gordon W.
    GASTROENTEROLOGY, 2022, 162 (07) : S233 - S234
  • [40] Improvement in Fatigue With Mirikizumab Therapy Is Associated With Clinical Remission and Pain Improvements but Not With Endoscopic Response in Patients With Moderately-to-Severely Active Crohn's Disease
    Regueiro, Miguel
    Fischer, Monika
    Rubin, David T.
    Hibi, Toshifumi
    Bossuyt, Peter
    Juillerat, Pascal
    Pollack, Paul
    Zhou, Xian
    Protic, Marijana
    Gibble, Theresa Hunter
    Chan, Lai-Shan
    Carlier, Hilde
    Hindryckx, Pieter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S602 - S603
12345